MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacc.2019.09.038

Медицинская библиотека · Journal of the American College of Cardiology · 2019

Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction.

Chichareon Ply, Modolo Rodrigo, Collet Carlos, Tenekecioglu Erhan, Vink Maarten A, Oh Pyung Chun, Ahn Jung-Min, Musto Carmine, Díaz de la Llera Luis S, Cho Young-Seok, Violini Roberto, Park Seung-Jung, Suryapranata Harry, Piek Jan J, de Winter Robbert J, Wykrzykowska Joanna J, Spaulding Christian, Kang Woong Chol, Slagboom Ton, Hofma Sjoerd H, Wijnbergen Inge F, Di Lorenzo Emilio, Pijls Nico H, Räber Lorenz, Brugaletta Salvatore, Sabaté Manel, Stoll Hans-Peter, Stone Gregg W, Windecker Stephan, Onuma Yoshinobu, Serruys Patrick W

СтатьяПоддержка исследования: вне правительства СШАNetwork Meta-AnalysisПеревод в очереди

Аннотация

BACKGROUND

To date, no specific drug-eluting stent (DES) has fully proven its superiority over others in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention.

OBJECTIVES

The purpose of this study was to compare the safety and efficacy of coronary artery stents in STEMI patients in a patient-level network meta-analysis.

METHODS

Eligible studies were dedicated randomized controlled trials comparing different stents in STEMI patients undergoing percutaneous coronary intervention with at least 12 months of clinical follow-up. Of 19 studies identified from the published data, individual patient data were collected in 15 studies with 10,979 patients representing 87.7% of patients in the overall network of evidence. The primary endpoint was the composite of cardiac death, reinfarction, or target lesion revascularization.

RESULTS

Overall, 8,487 (77.3%) of 10,979 STEMI patients were male and the mean age was 60.7 years. At a median follow-up of 3 years, compared with bare-metal stents (BMS), patients treated with paclitaxel-, sirolimus-, everolimus-, or biolimus-eluting stents had a significantly lower risk of the primary endpoint (adjusted hazard ratios [HRs]: 0.74 [95% confidence interval (CI): 0.63 to 0.88], 0.65 [95% CI: 0.49 to 0.85], 0.70 [95% CI: 0.53 to 0.91], and 0.66 [95% CI: 0.49 to 0.88], respectively). The risk of primary endpoint was not different between patients treated with BMS and zotarolimus-eluting stents (adjusted HR: 0.83 [95% CI: 0.51 to 1.38]). Among patients treated with DES, no significant difference in the risk of the primary outcome was demonstrated. Treatment with second-generation DES was associated with significantly lower risk of definite or probable stent thrombosis compared with BMS (adjusted HR: 0.61 [95% CI: 0.42 to 0.89]) and first-generation DES (adjusted HR: 0.56 [95% CI: 0.36 to 0.88]).

CONCLUSIONS

In STEMI patients, DES were superior to BMS with respect to long-term efficacy. No difference in long-term efficacy and safety was observed among specific DES. Second-generation were superior to first-generation DES in reducing stent thrombosis. (Clinical Outcomes After Primary Percutaneous Coronary Intervention [PCI] Using Contemporary Drug-Eluting Stent [DES]: Evidence From the Individual Patient Data Network Meta-Analysis; CRD42018104053).

Для цитирования: Chichareon Ply, Modolo Rodrigo, Collet Carlos, Tenekecioglu Erhan, Vink Maarten A, Oh Pyung Chun, Ahn Jung-Min, Musto Carmine, Díaz de la Llera Luis S, Cho Young-Seok, Violini Roberto, Park Seung-Jung, Suryapranata Harry, Piek Jan J, de Winter Robbert J, Wykrzykowska Joanna J, Spaulding Christian, Kang Woong Chol, Slagboom Ton, Hofma Sjoerd H, Wijnbergen Inge F, Di Lorenzo Emilio, Pijls Nico H, Räber Lorenz, Brugaletta Salvatore, Sabaté Manel, Stoll Hans-Peter, Stone Gregg W, Windecker Stephan, Onuma Yoshinobu, Serruys Patrick W. Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction.. Journal of the American College of Cardiology. 2019. DOI: 10.1016/j.jacc.2019.09.038.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.